These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12421268)

  • 21. Effective control of refractory pulmonary hypertension after cardiac operations.
    Fullerton DA; Jaggers J; Piedalue F; Grover FL; McIntyre RC
    J Thorac Cardiovasc Surg; 1997 Feb; 113(2):363-8; discussion 368-70. PubMed ID: 9040631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats.
    Horstman DJ; Frank DU; Rich GF
    Anesth Analg; 1998 Jan; 86(1):74-81. PubMed ID: 9428855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose response of intravenous sildenafil on systemic and regional hemodynamics in hypoxic neonatal piglets.
    Haase E; Bigam DL; Cravetchi O; Cheung PY
    Shock; 2006 Jul; 26(1):99-106. PubMed ID: 16783205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension.
    Max M; Kuhlen R; Dembinski R; Rossaint R
    Intensive Care Med; 1999 Oct; 25(10):1147-54. PubMed ID: 10551974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo.
    Holm P; Liska J; Franco-Cereceda A
    Cardiovasc Res; 1998 Mar; 37(3):765-71. PubMed ID: 9659461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of chronic hypoxic pulmonary hypertension in rats by cyclooxygenase products and by nitric oxide.
    Russell P; Wright C; Kapeller K; Barer G; Howard P
    Eur Respir J; 1993 Nov; 6(10):1501-6. PubMed ID: 7509294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension.
    Patterson KW; Deb B; Kavanagh BP; Pearl RG
    Pharmacology; 1999 May; 58(5):246-51. PubMed ID: 10087465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tanshinone IIA modulates pulmonary vascular response to agonist and hypoxia primarily via inhibiting Ca2+ influx and release in normal and hypoxic pulmonary hypertension rats.
    Wang J; Dong MQ; Liu ML; Xu DQ; Luo Y; Zhang B; Liu LL; Xu M; Zhao PT; Gao YQ; Li ZC
    Eur J Pharmacol; 2010 Aug; 640(1-3):129-38. PubMed ID: 20460121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
    Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets.
    Perreault T; Berkenbosch JW; Barrington KJ; Decker ER; Wu C; Brock TA; Baribeau J
    Pediatr Res; 2001 Sep; 50(3):374-83. PubMed ID: 11518825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac surgery and inhaled nitric oxide: indication and follow-up (2-4 years).
    Yahagi N; Kumon K; Tanigami H; Watanabe Y; Haruna M; Hayashi H; Imanaka H; Takeuchi M; Takamoto S
    Artif Organs; 1998 Oct; 22(10):886-91. PubMed ID: 9790088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II type 1 receptor blockade partially attenuates hypoxia-induced pulmonary hypertension in newborn piglets: relationship with the nitrergic system.
    Camelo JS; Martins AR; Rosa E; Ramos SG; Hehre D; Bancalari E; Suguihara C
    Braz J Med Biol Res; 2012 Feb; 45(2):163-71. PubMed ID: 22310488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic therapy of persistent pulmonary hypertension of the newborn.
    Weinberger B; Weiss K; Heck DE; Laskin DL; Laskin JD
    Pharmacol Ther; 2001 Jan; 89(1):67-79. PubMed ID: 11316514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of vasopressin on a porcine model of persistent pulmonary hypertension of the newborn.
    Amer R; Elsayed YN; Graham MR; Sikarwar AS; Hinton M; Dakshinamurti S
    Pediatr Pulmonol; 2019 Mar; 54(3):319-332. PubMed ID: 30644649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral blood flow during treatment for pulmonary hypertension.
    Kusuda S; Shishida N; Miyagi N; Hirabayashi M; Kim TJ
    Arch Dis Child Fetal Neonatal Ed; 1999 Jan; 80(1):F30-3. PubMed ID: 10325808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a phosphodiesterase 5 inhibitor on pulmonary and cerebral arteries of newborn piglets with chronic hypoxia-induced pulmonary hypertension.
    Fike CD; Kaplowitz M; Zhang Y; Dantuma M; Madden JA
    Neonatology; 2012; 101(1):28-39. PubMed ID: 21791937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of levcromakalim in neonatal porcine pulmonary hypertension.
    Ambalavanan N; Bulger A; Ware J; Philips J
    Biol Neonate; 2001 Jul; 80(1):74-80. PubMed ID: 11474154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged hypoxia augments L-citrulline transport by system A in the newborn piglet pulmonary circulation.
    Fike CD; Sidoryk-Wegrzynowicz M; Aschner M; Summar M; Prince LS; Cunningham G; Kaplowitz M; Zhang Y; Aschner JL
    Cardiovasc Res; 2012 Aug; 95(3):375-84. PubMed ID: 22673370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of magnesium sulphate in severe persistent pulmonary hypertension of the newborn.
    Chandran S; Haqueb ME; Wickramasinghe HT; Wint Z
    J Trop Pediatr; 2004 Aug; 50(4):219-23. PubMed ID: 15357561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.